← All trials
NCT07109726
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 23, 2025
- Primary completion
- Dec 30, 2028
- Completion date
- Feb 28, 2029
- First posted
- Aug 7, 2025
- Last posted
- Nov 26, 2025
- Enrollment
- 205
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Terremoto Biosciences Inc.Lead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.